Translating an Efficacious Illness Management Intervention for Youth With Asthma
2 other identifiers
interventional
75
1 country
1
Brief Summary
The propose of the study is to test the effectiveness of Reach for Control (RFC) as compared to Michigan MATCH to improve asthma symptoms, asthma management and lung functioning and to decrease ED visits and admissions for youth with poorly controlled asthma when integrated into hospital emergency departments and delivered by community health workers. The study is a hybrid implementation-effectiveness design and will test RFC for use in real world, public healthcare settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2017
CompletedFirst Posted
Study publicly available on registry
October 23, 2017
CompletedStudy Start
First participant enrolled
February 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2023
CompletedResults Posted
Study results publicly available
April 4, 2024
CompletedApril 4, 2024
April 1, 2024
5.5 years
October 18, 2017
February 19, 2024
April 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Emergency Department Visits
Emergency department visits will be obtained from electronic medical records
Change from Baseline at 6 months, 12 months, and 18 months
Secondary Outcomes (2)
Family Asthma Management System Scale
Change from Baseline at 6 months, change from Baseline at 12 months and change from Baseline at 18 months
Asthma Symptom Frequency
Change from Baseline at 6 months, change from Baseline at 12 months and change from Baseline at 18 months
Study Arms (2)
Reach for Control
EXPERIMENTALReach For Control is a multi-component, home-based family therapy that targets the multiple causes of poor adolescent asthma management across individual, family and community systems.
Michigan MATCH
ACTIVE COMPARATORProgram endorsed by the State of Michigan for treatment of poorly controlled asthma.
Interventions
In Phase 1 (weeks 1-4), the CHW conducts an initial intake and then completes a comprehensive functional analysis (FA) of behavior to determine the causes of poor asthma management for each youth regarding asthma management. In Phase 2 (weeks 5-20) is a treatment phase and consists of a combination of mandatory cognitive-behavioral skills training (CBST) modules (received by all families) and flexible CBST modules chosen and individualized based on the results of the Phase 1 FA. This includes but not limited to In-vivo Asthma Skills Training, Improving Family Communication and Behavioral Contracting. Phase 3 (weeks 21-24) involves termination planning and relapse prevention
Managing Asthma Through Case Management in Home (MATCH) is the current intervention provided by WCHAP to youth with poorly controlled asthma and their families.
Eligibility Criteria
You may qualify if:
- Adolescent/Parent:
- Child aged 12 years, 0 months to 16 years, 11 months
- Moderate to severe persistent asthma
- Child seen in the CHM emergency department for treatment of asthma exacerbation
- Child has experienced 2 or more ED visits and/ or inpatient admissions in prior 12 months (i.e. poorly controlled asthma)
- Parent/ legal guardian willing to participate in home-based family treatment
- Child and family resides within 20 miles of CHM (allows for home-based data collection and intervention)
You may not qualify if:
- Adolescent/Parent:
- Child is currently in an out-of-home placement
- Schizophrenia or other psychosis on the part of the youth or parent
- Current suicidality or homicidality on the part of the youth or parent
- Cognitive impairment or learning disability that prevents comprehension of research measures on the part of parent or youth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
Results Point of Contact
- Title
- Deborah Ellis, Ph.D.
- Organization
- Wayne State University
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah A Ellis, Ph.D
Wayne State University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Family Medicine and Public Health Sciences
Study Record Dates
First Submitted
October 18, 2017
First Posted
October 23, 2017
Study Start
February 1, 2018
Primary Completion
August 8, 2023
Study Completion
August 8, 2023
Last Updated
April 4, 2024
Results First Posted
April 4, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Indefinitely
- Access Criteria
- In light of the sensitive nature of the treatment data contained in the data set, as well as the participation of children, data and associated documentation will be made available to users only under a specific data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying the data after analyses are completed. Furthermore, audiotaped session recordings will not be shared, as these include voice identifiers and it is not possible to de-identify the recordings; costs of transcription of sessions given their length and number are beyond the scope of the study.
Data will be made available at the end of the study through presentations at scientific conferences and publications in peer-reviewed scientific journals. All final peer-reviewed manuscripts that result from the study will be submitted to PubMed Central. In addition, final dataset from the trial will be shared. Identifiers will be removed from the data prior to any release of the dataset.